We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Verastem Enters Biomarker Agreement with LabCorp

News   Jan 10, 2013

 
Verastem Enters Biomarker Agreement with LabCorp
 
 
 

RELATED ARTICLES

Blood Test Could Reveal High Risk Heart Patients in Need of Treatment

News

Without occasionally looking under the hood, it’s difficult to predict whether expensive car repairs lie ahead. In a similar way, preventive cardiologists are looking for ways to detect early stage heart disease in people who aren’t currently in treatment.

READ MORE

Compound Targets Previously “Undruggable” STAT3 To Combat Cancer

News

A compound has been developed that targets transcription factor STAT3, offering a new approach to a previously “undruggable” target.

READ MORE

The Gut Could Be Key To Cutting Chemo’s Side Effects

News

Scientists have observed several simultaneous reactions in mice given a chemotherapy drug... their gut bacteria and tissue changed, their blood and brains showed signs of inflammation, and their behaviors suggested they were fatigued and cognitively impaired.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE